In this condition, we predicted that the regulation of resveratrol on ANPEP, CD69, ITGAL, PTPRC, CD34, ITGA1, CCL2, and SOX2 expression were beneficial to the treatment of NSCLC. Here, ITGAL is linked to non-small cell lung carcinoma.